pharmacokinetics and safety of a new 1200 mg single dose delayed release mesalazine microgranule formulation

The treatment of Inflammatory Bowel Diseases (IBDs) requires a relative high therapeutic daily dose of mesalazine and thus, the drug formulation need to be well tolerate and safe. A new pH-dependent controlled release 5-ASA microgranule formulation in 1.2 g sachets has been developed. The plasma levels of both the active principle 5-ASA and the main metabolite N-Acetyl-5-ASA, after oral administration of the new formulation or after an equimolar dose of three separated enteric coated 400 mg tablets administered in the same time (Pentacol® 400, SOFAR, Milan, ITALY), were measured with a validated high performance liquid chromatography-tandem mass spectrometry method. C max , t max and AUC values were considered as primary variables and the drug safety was the secondary one. The plasma 5-ASA concentration appearance was faster after microgranule administration ( tmax of 8.1 hours) than after the reference tablets assumption (tmax of 10.6 hours). The Cmax and AUC values were similar for both formulations and the kinetic of plasma disappearance of the test formulation was slight faster. The intersubject variability was lower after administration of the microgranules with a %CV of 17.5% vs 40.4% for the tablets (n=23), due to a more controlled homogeneous drug release from the granule format. The N-Acetyl-5ASA metabolite presents a similar plasma profile of the 5-ASA for both formulations. The use of microgranules is safe and will allow to reduce the daily dosages, by improving the patients compliance also in presence of difficulty to swallow large tablets

Bile acid structure-activity relationship: evaluation of bile acid lipophilicity using 1-octanol/water partition coefficient and reverse phase HPLC.

Two independent methods have been developed and compared to determine the lipophilicity of a representative series of naturally occurring bile acids (BA) in relation to their struc- ture. The BA included cholic acid (CA), chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA), deoxycholic acid (DCA), hyodeoxycholic acid (HDCA), ursocholic acid (UCA), hyocholic acid (HCA), as well as their glycine and taurine ami- dates. Lipophilicity was determined using a 1-octanol/water shake-flask procedure and the experiments were performed at different pH and ionic strengths and at initial BA concentrations below their critical micellar concentrations (CMC) and the water solubility of the protonated form. The experimental data show that both the protonated (HA) and ionized (A-) forms of BA can distribute in 1-octanol, and consequently a partition co- efficient for HA (logP' HA) and for A- (logP' A-) must be defined. An equation to predict a weighted apparent distribution coefficient (D) value as a function of pH and pKa has been de- veloped and fits well with the experimental data. Differences be- tween logP for protonated and ionized species for unconjugated BA were in the order of 1 log unit, which increased to 2 for glycine-amidated BA. The partition coefficient of the A- form in- creased with Na+ concentration and total ionic strength, suggest- ing an ion-pair mechanism for its partition into 1-octanol. Lipophilicity was also assessed using reverse phase chromatogra- phy (C-18-HPLC), and a capacity factor (K') for ionized species was determined. Despite a broad correlation with the logP data, some BA behaved differently. The logP values showed that the order of lipophilicity was DCA >CDCA >UDCA > HDCA > HCA>CA >UCA for both the protonated and ionized uncon- jugated and glycine-amidated BA, while the K' data showed an inversion for some BA, i.e., DCA>CDCA >CA> HCA> UDCA > HDCA >UCA. The logP data fitted well with other in- direct measurements of BA monomeric lipophilicity such as al- bumin binding or accessible total hydrophobic surface area data calculated by energy minimization and molecular computer graphics. Differences between unconjugated and amidated BA are consistent with the presence of an amide bond and a lower pKa when pH dependence was studied. Capacity factors, on the other hand, were related to properties of BA micelles such as cholesterol-solubilizing capacity and membrane disruption, reflecting the BA detergency. The extrapolation of these data to biological phenomena must carefully consider the experimental conditions in which the interaction occurs, Le., total BA concen- tration, ionic strength, Na+ concentration, and pH, which in turn determine the BA species existing in solution that coul

Physicochemical and biological properties of natural and synthetic C-22 and C-23 hydroxylated bile acids.

In order to define the effect of a side chain hydroxy group on bile acid (BA) physicochemical and biological properties, 23-hydroxylated bile acids were synthesized following a new efficient route involving the alpha-oxygenation of silylalkenes. 22-Hydroxylated bile acids were also studied. The synthesized bile acids included R and S epimers of 3 alpha,7 alpha,23-trihydroxy-5 beta-cholan-24-oic acid (23R epimer: phocaecholic acid), 3 alpha,12 alpha,23-trihydroxy-5 beta-cholan-24-oic (23R epimer: bitocholic acid), and 3 alpha,7 beta,23-trihydroxy-5 beta-cholan-24-oic acid. A 3 alpha,7 alpha,22-trihydroxy-5 beta-cholan-24-oic acid (haemulcholic acid) was also studied. The presence of a hydroxy group on the side chain slightly modified the physicochemical behavior in aqueous solution with respect to common BA: the critical micellar concentration (CMC) and the hydrophilicity were similar to naturally occurring trihydroxy BA such as cholic acid. The pKa value was lowered by 1.5 units with respect to common BA, being 3.8 for all the C-23 hydroxy BA. C-22 had a higher pKa (4.2) as a result of the increased distance of the hydroxy group from the carboxy group. When the C-23 hydroxylated BA were intravenously administered to bile fistula rats, they were efficiently recovered in bile (more than 80% unmodified) while the corresponding analogs, lacking the 23- hydroxy group, were almost completely glycine- or taurine-conjugated. On the other hand, the C-22 hydroxylated BA were extensively conjugated with taurine and less than 40% of the administered dose was secreted without being conjugated. In the presence of intestinal bacteria, they were mostly metabolized to the corresponding 7-dehydroxylated compound similar to common BA with the exception of bitocholic acid which was relatively stable. The presence of a hydroxy group at the C-23 position increased the acidity of the BA and this accounted for poor absorption within the biliary tree and efficient biliary secretion without the need for conjugation. 3 alpha,7 beta-23 R/S trihydroxy-5 beta-cholan-24-oic acids could improve the efficiency of ursodeoxycholic acid (UDCA) for gallstone dissolution or cholestatic syndrome therapy, as it is relatively hydrophilic and efficiently secreted into bile without altering the glycine and taurine hepatic pool

Protein Microdeposition Using a Conventional Ink-Jet Printer

Many recent bioanalytical systems based on immunologic and hybridization reactions in a mono- or bidimensional microarray format require technology that can produce arrays of spots containing biospecific molecules. Some microarray deposition instruments are commercially available, and other devices have been described in recent papers. We describe a system obtained by adapting a commercial ink-jet printer and used to produce mono- and bidimensional arrays of spots containing horseradish peroxidase on cellulose paper. In a few minutes, it was possible to obtain bidimensional arrays containing several thousands of spots with a diameter as low as 0.2 mm, with each of which requiring only a few nanoliters of the enzyme deposition solution. The quantity of enzyme in each spot was evaluated with a chemiluminescent reaction and a charge-coupled device-based, low-light imaging luminograph. The chemiluminescence measurements revealed that the reproducibility of the enzyme deposition was satisfactory for analytical purposes, with the variation coefficients being lower than 10% in almost all cases

Comprehensive profiling of diverse genetic reporters with application to whole-cell and cell-free biosensors

Whole-cell and cell-free transcription-translation biosensors have recently become favorable alternatives to conventional detection methods, as they are cost-effective, environmental friendly, and easy to use. Importantly, the biological responses from the biosensors need to be converted into a physicochemical signal for easy detection, and a variety of genetic reporters have been employed for this purpose. Reporter gene selection is vital to a sensor performance and application success. However, it was largely based on trial and error with very few systematic side-by-side investigations reported. To address this bottleneck, here we compared eight reporters from three reporter categories, i.e., fluorescent (gfpmut3, deGFP, mCherry, mScarlet-I), colorimetric (lacZ), and bioluminescent (luxCDABE from Aliivibrio fischeri and Photorhabdus luminescens, NanoLuc) reporters, under the control of two representative biosensors for mercury- and quorum-sensing molecules. Both whole-cell and cell-free formats were investigated to assess key sensing features including limit of detection (LOD), input and output dynamic ranges, response time, and output visibility. For both whole-cell biosensors, the lowest detectable concentration of analytes and the fastest responses were achieved with NanoLuc. Notably, we developed, to date, the most sensitive whole-cell mercury biosensor using NanoLuc as reporter, with an LOD 64 50.0 fM HgCl2 30 min postinduction. For cell-free biosensors, overall, NanoLuc and deGFP led to shorter response time and lower LOD than the others. This comprehensive profile of diverse reporters in a single setting provides a new important benchmark for reporter selection, aiding the rapid development of whole-cell and cell-free biosensors for various applications in the environment and health

Integration of amorphous silicon balanced photodiodes and thin film heaters for biosensing application

This work presents the development and testing of an integrated system for on-chip detection of thermochemiluminescent biomolecules. The activation energy of the reaction is provided by a transparent structure of thin film heaters deposited on one side of a glass substrate. Light, passing through the substrate, reaches an array of amorphous silicon differential structure deposited on the opposite side of the glass substrate. The structure is designed to perform differential current measurements between a light- shielded diode, whose current is sensitive only to temperature, and a photosensor, sensitive to both incident light and temperature. The device therefore balances the thermal variations of the photodiode current and reduces the dark-current noise. These features make the presented system very appealing as highly miniaturized micro-analytical devices for biosensing applications

Ultra-small octahedral PtNP-labeled antibodies as an ultrasensitive nanozyme probe for chemiluminescence detection in bioanalytics

Chemiluminescence (CL)-based probes are one of the most sensitive detection principles in nanodiagnostics. A widely used system is the CL substrate for peroxidase (HRP) employed to label a variety of molecules ranging from small steroids to protein. The CL cocktail for HRP is based on luminol or its analogues, hydrogen peroxide, and an enhancer, allowing the detection of submolar concentrations of the enzyme-labeled analyte. The catalyst of the CL reaction, namely HRP, can be replaced by other more practical and highly stable nano-catalysts/nanozymes; among them, recent studies have demonstrated the superior performance of Pt nanomaterials [1]. In this work, we propose the use of ultra-small (3 nm) citrate-coated octahedral Pt nanocrystals prepared by a new wet chemical reduction method in aqueous environment and conjugated to a secondary human IgG antibody, as an ultrasensitive probe for luminol/hydrogen peroxide CL detection. Conjugates with different nanocrystal-to-antibody molar ratios were first fully characterized and purified by Field-Flow Fractionation (FFF) [2]. FFF confirms the homogeneous size of the conjugated which represents a fundamental parameter for their efficiency. The FFF-selected purified conjugates are homogeneous in size and highly concentrated, and readily available for downstream CL tests, an important requirement for the use of FFF as semi-prep step. First results demonstrate the applicability of Pt nanocrystals as probes for CL detection. Indeed the Pt nanocrystals-antibodies CL signal has been measured for the different nanoparticles-IgG molar ratios, showing an increasing signal as a function of nanoparticles concentration with the possibility to detect IgG down to 10-12 M, value close to that obtained using HRP [3]. In addition, the light signal reaches a steady state value for more than 30 minutes, thus facilitating the assay handling. These results paves the way to the use of Pt nanomaterials, highly monodisperse in size and shape and with easy-to-remove coating, for the production of highly efficient catalysts/nanozymes for CL applications and the development of simple and rapid new tests

A new iron free treatment with oral fi sh cartilage polysaccharide for iron defi ciency chronic anemia in infl ammatory bowel diseases: A pilot study

Abstract AIM: To investigate the effect of a new oral preparation, highly concentrated in fish cartilage, in a group of infl ammatory bowel diseases (IBD) patients with chronic iron defi cient anemia. METHODS: In an open label pilot study, we supplemented a group of 25 patients (11 with Crohn's disease and 14 with ulcerative colitis) in stable clinical conditions and chronic anemia with a food supplement which does not contain iron but contains a standardized fraction of fish cartilage glycosaminoglycans and a mixture of antioxidants (Captafer Medestea, Turin, Italy). Patients received 500 mg, twice a day during meals, for at least 4 mo. Patients were suggested to maintain their alimentary habit. At time 0 and after 2 and 4 mo, emocrome, sideremia and ferritin were examined. Paired data were analyzed with Student's t test. RESULTS: Three patients relapsed during the study (2 in the 3 rd mo, 1 in the 4 th mo), two patients were lost to follow up and two patients dropped out (1 for orticaria, 1 for gastric burning). Of the remaining 18 patients, levels of serum iron started to rapidly increase within the 2 nd mo of treatment, P < 0.05), whereas serum ferritin and hemoglobin needed a longer period to signifi cantly improve their serum levels (mo 4) P < 0.05). The product was safe, easy to administer and well tolerated by patients. CONCLUSION: These data suggest a potential new treatment for IBD patients with iron defi ciency chronic anemia and warrant further larger controlled studies

Determination of free and amidated bile acids by high-performance liquid chromatography with evaporative light-scattering mass detection

A simple reverse phase high-performance liquid chromatographic method for a simultaneous analysis of free, glycine- and taurine-amidated bile acids is described. The resolution of ursodeoxycholic, cholic, chenodeocycholic, deoxycholic, and lithocholic acids, either free or amidated with glycine and taurine, is achieved using a C-18 octadecylsilane column (30 cm length, 4 micron particle size) with a gradient elution of aqueous methanol (65—-75%) containing 15 mM ammonium acetate, pH 5.40, at 37 degrees C. The separated bile acids are detected with a new evaporative light-scattering mass detector and by absorbance at 200 nm. A complete resolution of the 16 bile acids, including the internal standard nor-deoxycholic acid, is obtained within 55 min. Using the light-scattering mass detector, amidated bile acids and, for the first time, free bile acids can be detected with similar detection limits in the order of 2-7 nmol. The new detector improves the baseline and the signal-to-noise ratio over the UV detection as it is not affected by impurities present in the samples with higher molar absorptivity than bile acids or by the change in the mobile phase composition during the gradient. The method fulfills all the standard requirements of precision and accuracy and the linearity of the mass detector is over 5 decade the detection limit. The new method has been used for the direct analysis of bile acid in stools and bile with only a preliminary clean-up procedure using a C-18 reverse phase extraction

Bioengineered bioluminescent magnetotactic bacteria as a powerful tool for chip-based whole-cell biosensors

This paper describes the generation of genetically engineered bioluminescent magnetotactic bacteria (BL-MTB) and their integration into a microfluidic analytical device to create a portable toxicity detection system. Magnetospirillum gryphiswaldense strain MSR-1 was bioengineered to constitutively express a red-emitting click beetle luciferase whose bioluminescent signal is directly proportional to bacterial viability. The magnetic properties of these bacteria have been exploited as "natural actuators" to transfer the cells in the chip from the reaction to the detection area, optimizing the chip's analytical performance. A robust and cost-effective biosensor for the evaluation of sample toxicity, named MAGNETOX, based on lens-free contact imaging detection, has been developed. A microfluidic chip has been fabricated using multilayered black and transparent polydimethyl siloxane (PDMS) in which BL-MTB are incubated for 30 min with the sample, then moved by microfluidics, trapped, and concentrated in detection chambers by an array of neodymium-iron-boron magnets. The chip is placed in contact with a cooled CCD via a fiber optic taper to perform quantitative bioluminescence imaging after addition of luciferin substrate. A model toxic compound (dimethyl sulfoxide, DMSO) and a bile acid (taurochenodeoxycholic acid, TCDCA) were used to investigate the analytical performance of the MAGNETOX. Incubation with DMSO and TCDCA drastically reduces the bioluminescent signal in a dose-related manner. The generation of bacteria that are both magnetic and bioluminescent combines the advantages of easy 2D cell handling with ultra sensitive detection, offering undoubted potential to develop cell-based biosensors integrated into microfluidic chips